Physician
Pathology
Dr. Anna Mhoyan, MD
|
|
Give Review
Anna Mhoyan practices Pathology. She went to Yerevan State Medical University. She received 1 awards: "Meaningful Use Stage 1 Certification". Anna Mhoyan has written publications. She has 17 publications published with PubMed. The lastest publication is: 'Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to ...'
Publications
- Xenoantibody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver.
- Predominant expression of Th2 cytokines and interferon-gamma in xenogeneic cardiac grafts undergoing acute vascular rejection.
- Predominant expression of the Th2 response in chronic cardiac allograft rejection.
- Prevention of chronic rejection with immunoregulatory cells induced by intrathymic immune modulation with class I allopeptides.
- Chronic cardiac allograft rejection in a rat model disparate for one single class I MHC molecule is associated with indirect recognition by CD4(+) T cells.
- Epithelioid hemangioendothelioma of the lung diagnosed by transesophageal endoscopic ultrasound-guided fine needle aspiration: a case report.
- Cavernous hemangioma of the thalamus.
- Delayed death in sudden infant death syndrome: a San Diego SIDS/SUDC Research Project 15-year population-based report.
- Placenta accreta: an association with fibroids and Asherman syndrome.
- Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. I. Correlation of graft survival with antidonor IgG antibody su...
- Modulation of alloimmunity with class I MHC peptides: mechanisms of action.
- Intrathymic immune regulation with donor class I allopeptides leads to the development of immunoregulatory cells that maintain tolerance to cardiac allografts.
- The role of donor class I major histocompatibility complex peptides in the induction of allograft tolerance.
- Allochimeric class I MHC molecules prevent chronic rejection and attenuate alloantibody responses.
- Allochimeric class I MHC inhibits chronic rejection in cardiac allografts.
- Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to ...
Doctors Specialties
- Pathology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
University of California San Diego -
Yerevan State Medical University
Helpful Reviews
Similar Doctors
|
|
Dr. Adriana A. Bedoya, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tom C. Deroche, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia A. Behling, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Farnaz Hasteh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth H. Lasser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian Datnow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julia Phillipson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tyler P. Youngkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward M. Kasun, MD |
|
|
Dr. Daryoush Saeed-Vafa, MD |